Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001309014-17-000167
Filing Date
2017-03-01
Accepted
2017-03-01 11:10:32
Documents
2
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_10883.htm 6-K 9677
2 EX-99.1 exhibit1.htm EX-99.1 12740
  Complete submission text file 0001309014-17-000167.txt   23472
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-16174 | Film No.: 17652244
SIC: 2834 Pharmaceutical Preparations